Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy

This study is testing whether a combination of two electrical nerve stimulation techniques — transcutaneous electrical nerve stimulation (TENS) and neuromuscular electrical stimulation (NMES) — delivered via a digital health monitoring approach can reduce symptoms of diabetic peripheral neuropathy, such as pain, numbness, and loss of sensation in the legs and feet, in adults with type 2 diabetes. Diabetic neuropathy is a common and distressing complication of diabetes, and physical therapies that stimulate nerve function may offer relief alongside standard medications. Adults aged 55 to 65 with diagnosed type 2 diabetes, peripheral neuropathy confirmed by a validated screening tool, a BMI above 25, and controlled blood pressure are eligible, while those with heart failure, metal implants, cardiac pacemakers, foot ulcers, other causes of neuropathy, or anemia are excluded. Participants will attend 30-minute TENS and NMES (or sham) sessions three times per week for 10 weeks, while continuing their standard diabetic medications. This summary was prepared to help patients understand the study in plain language.